Nicole Grimm represents companies in connection with health care and Food and Drug Administration-related matters, focusing on advising pharmaceutical and medical device manufacturers, health insurers and other health care industry clients in connection with regulatory compliance issues and complex transactional matters.


Ms. Grimm’s recent experience includes counseling on the $17.3 billion acquisition of a major health insurer, the $6.1 billion acquisition of a major medical device manufacturer, the $3 billion divestiture of a major consumer products manufacturer, the acquisition of a national pharmacy chain, the initial public offerings of pharmaceutical and medical device manufacturers, and the acquisitions of health and life sciences data analysis and management companies.

She also advises on governmental investigation matters and complex civil litigation, including qui tam matters, securities litigation and class actions.

Ms. Grimm is active in pro bono activities. In 2013, Ms. Grimm received the Klepper Prize for Volunteer Excellence from the Legal Aid Society of the District of Columbia for her work on behalf of domestic violence survivors, and she currently serves in a leadership role with the Impact Project in Skadden’s Washington, D.C. office.



  • J.D., American University Washington College of Law, 1999 (summa cum laude)
  • B.A., American University, 1995 (magna cum laude)


  • District of Columbia
  • Missouri
  • U.S. District Court for the District of Columbia


  • American Bar Association


  • Spanish

Nicole L. Grimm

Counsel, Litigation; Health Care and Life Sciences